Quinoline inhibitors of cGMP phosphodiesterase

Details Quinoline inhibitors of cGMP phosphodiesterase Quinoline inhibitors of cGMP phosphodiesterase

2008-05-27

2008-05-27

Davis, Zinna N. (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S159000

Reexamination Certificate

active

11640732

ABSTRACT:
Compounds of the formula (I)are useful as inhibitors of cGMP PDE especially Type 5.

REFERENCES:
patent: 3362954 (1968-01-01), Surrey et al.
patent: 4343804 (1982-08-01), Munson, Jr. et al.
patent: 4840972 (1989-06-01), Effland et al.
patent: 5296484 (1994-03-01), Coghlan et al.
patent: 5482941 (1996-01-01), Terrett
patent: 5488055 (1996-01-01), Kumar et al.
patent: 5576322 (1996-11-01), Takase et al.
patent: 5716993 (1998-02-01), Ozaki et al.
patent: 6002008 (1999-12-01), Wissner et al.
patent: 6087368 (2000-07-01), Macor et al.
patent: 6316438 (2001-11-01), Yu et al.
patent: 2005/0113358 (2005-05-01), Bi et al.
patent: 0336544 (1989-10-01), None
patent: 0480052 (1992-04-01), None
patent: 2258855 (1975-08-01), None
patent: WO94/22855 (1994-10-01), None
patent: WO96/05176 (1996-02-01), None
patent: WO98/07430 (1998-02-01), None
patent: WO98/08848 (1998-03-01), None
patent: WO98/16514 (1998-04-01), None
patent: WO 98/43960 (1998-10-01), None
patent: WO98/47874 (1998-10-01), None
patent: WO99/43674 (1999-09-01), None
patent: WO00/09506 (2000-02-01), None
patent: WO 00/18761 (2000-04-01), None
patent: WO01/21642 (2001-03-01), None
patent: WO01/68186 (2001-09-01), None
Savini et al., II Farmaco, 48 (6) pp. 805-825 (1993).
Eggert et al., Arch. Pharm. (Weinheim) 323 pp. 611-617 (1990).
Marecki et al., American Pharmaceutical Asso., Journal of Pharmaceutical Sciences, vol. 73, No. 8, pp. 1141-1143 (1984).
Jain et al., J. of Medicinal Chemistry, American Chemical Soc., vol. 11, No. 1 pp. 87-92 (1968).
Wright et al., J. of Medicinal Chemistry, American Chemical Soc., vol. 14, No. 11 pp. 1060-1066 (1971).
Terrett et al., Bioorganic & Medicinal Chemistry Letters, vol. 6, No. 15, pp. 1819-1824 (1996).
Elworthy et al., J. Med. Chem. vol. 40, pp. 2674-2687 (1997).
Ife et al., American Chemical Society, pp. 3413-3422 (1992).

Affiliated with

Also associated with

Rating

Quinoline inhibitors of cGMP phosphodiesterase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Quinoline inhibitors of cGMP phosphodiesterase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline inhibitors of cGMP phosphodiesterase will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3956981